PATENT CLAIM ANALYSIS

Application Number: 16218383
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "108000"]

Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions.

Claim (Index 5):
The method of  claim 1 , wherein the pain comprises arthritis pain.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15587108', '15378939', '15439774', '15801049', '15697267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8476451113043508
- 35 USC 102 Novelty (BERT): 0.5630344001169001
- Combined Prediction Score: 0.8191840401856058
- Mean Citation Score: 577.502648
- Max Citation Score: 579.5003
- Similarity Product: 312.69913029088974

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test